Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Brachytherapy for targeting the immune system in cervical cancer patients.
Linares I, Berenguer Frances MÁ, Cañas R, Najjari D, Gutiérrez C, Marín S, Comas S, Guedea F, Pujol M. Linares I, et al. Among authors: guedea f. BMC Immunol. 2023 Aug 9;24(1):23. doi: 10.1186/s12865-023-00559-y. BMC Immunol. 2023. PMID: 37559025 Free PMC article.
Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial).
Garcia-Tejedor A, Ortega-Exposito C, Salinas S, Luzardo-González A, Falo C, Martinez-Pérez E, Pérez-Montero H, Soler-Monsó MT, Bajen MT, Benitez A, Ortega R, Petit A, Guma A, Campos M, Plà MJ, Pernas S, Peñafiel J, Yeste C, Gil-Gil M, Guedea F, Ponce J, Laplana M. Garcia-Tejedor A, et al. Among authors: guedea f. Front Oncol. 2023 Aug 9;13:1184021. doi: 10.3389/fonc.2023.1184021. eCollection 2023. Front Oncol. 2023. PMID: 37621686 Free PMC article.
Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial.
Strnad V, Polgár C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Łyczek J, Guinot JL, Gutierrez Miguelez C, Slampa P, Allgäuer M, Lössl K, Polat B, Fietkau R, Schlamann A, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Dunst J, Gall C, Uter W; Groupe Européen de Curiethérapie and European Society for Radiotherapy and Oncology. Strnad V, et al. Among authors: guedea f. Lancet Oncol. 2023 Mar;24(3):262-272. doi: 10.1016/S1470-2045(23)00018-9. Epub 2023 Feb 1. Lancet Oncol. 2023. PMID: 36738756 Clinical Trial.
Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures.
Zamora V, Garin O, Suárez JF, Gutiérrez C, Guedea F, Cabrera P, Castells M, Herruzo I, Fumadó L, Samper P, Ferrer C, Regis L, Pont À, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Zamora V, et al. Among authors: guedea f. Clin Transl Radiat Oncol. 2023 Oct 29;44:100694. doi: 10.1016/j.ctro.2023.100694. eCollection 2024 Jan. Clin Transl Radiat Oncol. 2023. PMID: 38021091 Free PMC article.
IROCA-TES: Improving Quality in Radiation Oncology through Clinical Audits - Training and Education for Standardization.
Malicki J, Castro CL, Fundowicz M, Krengli M, Llacer-Moscardo C, Curcean S, Montplet CM, Carvalho L, Konstanty E, Barragan TH, Pisani C, Laszlo I, Garau MM, Kruszyna-Mochalska M, Lencart J, Zwierzchowska D, Serrano AR, Brezae A, Varela EL, Milecki P, Zannetti M, Coza O, Gonzalez E, Beldì D, Guedea F. Malicki J, et al. Among authors: guedea f. Rep Pract Oncol Radiother. 2023 Jul 25;28(3):429-432. doi: 10.5603/RPOR.a2023.0035. eCollection 2023. Rep Pract Oncol Radiother. 2023. PMID: 37795403 Free PMC article.
142 results